In the present study, the level of IL-10 in the serum and the lung was elevated after ERC treatment, suggesting that ERCs might protect the mice from pulmonary fibrosis by upregulating IL-10 both locally and systematically. The gene discussed is IL10; the disease is pulmonary fibrosis.